339 related articles for article (PubMed ID: 25850019)
21. Two-year study of the protective efficacy of the oral whole cell plus recombinant B subunit cholera vaccine in Peru.
Taylor DN; Cárdenas V; Sanchez JL; Bégué RE; Gilman R; Bautista C; Perez J; Puga R; Gaillour A; Meza R; Echeverria P; Sadoff J
J Infect Dis; 2000 May; 181(5):1667-73. PubMed ID: 10823767
[TBL] [Abstract][Full Text] [Related]
22. An Estimation of Private Household Costs to Receive Free Oral Cholera Vaccine in Odisha, India.
Mogasale V; Kar SK; Kim JH; Mogasale VV; Kerketta AS; Patnaik B; Rath SB; Puri MK; You YA; Khuntia HK; Maskery B; Wierzba TF; Sah B
PLoS Negl Trop Dis; 2015; 9(9):e0004072. PubMed ID: 26352143
[TBL] [Abstract][Full Text] [Related]
23. Alternative observational designs to estimate the effectiveness of one dose of oral cholera vaccine in Lusaka, Zambia.
Ferreras E; Blake A; Chewe O; Mwaba J; Zulu G; Poncin M; Rakesh A; Page AL; Quilici ML; Azman AS; Cohuet S; Ciglenecki I; Malama K; Chizema-Kawesha E; Luquero FJ
Epidemiol Infect; 2020 Mar; 148():e78. PubMed ID: 32167038
[TBL] [Abstract][Full Text] [Related]
24. Cholera vaccine field trials in east Pakistan. 2. Effectiveness in the field.
Benenson AS; Mosley WH; Fahimuddin M; Oseasohn RO
Bull World Health Organ; 1968; 38(3):359-72. PubMed ID: 5302329
[TBL] [Abstract][Full Text] [Related]
25. Comparison of two control groups for estimation of oral cholera vaccine effectiveness using a case-control study design.
Franke MF; Jerome JG; Matias WR; Ternier R; Hilaire IJ; Harris JB; Ivers LC
Vaccine; 2017 Oct; 35(43):5819-5827. PubMed ID: 28916247
[TBL] [Abstract][Full Text] [Related]
26. Feasibility and costs of a targeted cholera vaccination campaign in Ethiopia.
Teshome S; Desai S; Kim JH; Belay D; Mogasale V
Hum Vaccin Immunother; 2018; 14(10):2427-2433. PubMed ID: 29648523
[TBL] [Abstract][Full Text] [Related]
27. A randomized, non-inferiority trial comparing two bivalent killed, whole cell, oral cholera vaccines (Euvichol vs Shanchol) in the Philippines.
Baik YO; Choi SK; Olveda RM; Espos RA; Ligsay AD; Montellano MB; Yeam JS; Yang JS; Park JY; Kim DR; Desai SN; Singh AP; Kim IY; Kim CW; Park SN
Vaccine; 2015 Nov; 33(46):6360-5. PubMed ID: 26348402
[TBL] [Abstract][Full Text] [Related]
28. Oral vaccines against cholera: lessons from Vietnam and elsewhere.
Levine MM
Lancet; 1997 Jan; 349(9047):220-1. PubMed ID: 9014902
[TBL] [Abstract][Full Text] [Related]
29. Feasibility and effectiveness of oral cholera vaccine in an urban endemic setting in Bangladesh: a cluster randomised open-label trial.
Qadri F; Ali M; Chowdhury F; Khan AI; Saha A; Khan IA; Begum YA; Bhuiyan TR; Chowdhury MI; Uddin MJ; Khan JAM; Chowdhury AI; Rahman A; Siddique SA; Asaduzzaman M; Akter A; Khan A; Ae You Y; Siddik AU; Saha NC; Kabir A; Riaz BK; Biswas SK; Begum F; Unicomb L; Luby SP; Cravioto A; Clemens JD
Lancet; 2015 Oct; 386(10001):1362-1371. PubMed ID: 26164097
[TBL] [Abstract][Full Text] [Related]
30. Feasibility, coverage and cost of oral cholera vaccination conducted by icddr,b using the existing national immunization service delivery mechanism in rural setting Keraniganj, Bangladesh.
Khan AI; Khan IA; Siddique SA; Rahman A; Islam MT; Bhuiya MAI; Saha NC; Biswas PK; Saha A; Chowdhury F; Qadri F
Hum Vaccin Immunother; 2019; 15(6):1302-1309. PubMed ID: 30261152
[No Abstract] [Full Text] [Related]
31. Comparison of immune responses to a killed bivalent whole cell oral cholera vaccine between endemic and less endemic settings.
Desai SN; Akalu Z; Teferi M; Manna B; Teshome S; Park JY; Yang JS; Kim DR; Kanungo S; Digilio L
Trop Med Int Health; 2016 Feb; 21(2):194-201. PubMed ID: 26681205
[TBL] [Abstract][Full Text] [Related]
32. Feasibility of a preventive mass vaccination campaign with two doses of oral cholera vaccine during a humanitarian emergency in South Sudan.
Porta MI; Lenglet A; de Weerdt S; Crestani R; Sinke R; Frawley MJ; Van Herp M; Zachariah R
Trans R Soc Trop Med Hyg; 2014 Dec; 108(12):810-5. PubMed ID: 25311798
[TBL] [Abstract][Full Text] [Related]
33. Mass vaccination with a two-dose oral cholera vaccine in a refugee camp.
Legros D; Paquet C; Perea W; Marty I; Mugisha NK; Royer H; Neira M; Ivanoff B
Bull World Health Organ; 1999; 77(10):837-42. PubMed ID: 10593032
[TBL] [Abstract][Full Text] [Related]
34. Effectiveness of reactive oral cholera vaccination in rural Haiti: a case-control study and bias-indicator analysis.
Ivers LC; Hilaire IJ; Teng JE; Almazor CP; Jerome JG; Ternier R; Boncy J; Buteau J; Murray MB; Harris JB; Franke MF
Lancet Glob Health; 2015 Mar; 3(3):e162-8. PubMed ID: 25701994
[TBL] [Abstract][Full Text] [Related]
35. Cost-effectiveness of new-generation oral cholera vaccines: a multisite analysis.
Jeuland M; Cook J; Poulos C; Clemens J; Whittington D;
Value Health; 2009 Sep; 12(6):899-908. PubMed ID: 19824189
[TBL] [Abstract][Full Text] [Related]
36. Assessing different measures of population-level vaccine protection using a case-control study.
Ali M; You YA; Kanungo S; Manna B; Deen JL; Lopez AL; Wierzba TF; Bhattacharya SK; Sur D; Clemens JD
Vaccine; 2015 Nov; 33(48):6878-83. PubMed ID: 26364121
[TBL] [Abstract][Full Text] [Related]
37. Immune responses following one and two doses of the reformulated, bivalent, killed, whole-cell, oral cholera vaccine among adults and children in Kolkata, India: a randomized, placebo-controlled trial.
Kanungo S; Paisley A; Lopez AL; Bhattacharya M; Manna B; Kim DR; Han SH; Attridge S; Carbis R; Rao R; Holmgren J; Clemens JD; Sur D
Vaccine; 2009 Nov; 27(49):6887-93. PubMed ID: 19761838
[TBL] [Abstract][Full Text] [Related]
38. Field trial of oral cholera vaccines in Bangladesh.
Clemens JD; Sack DA; Harris JR; Chakraborty J; Khan MR; Stanton BF; Kay BA; Khan MU; Yunus M; Atkinson W
Lancet; 1986 Jul; 2(8499):124-7. PubMed ID: 2873397
[TBL] [Abstract][Full Text] [Related]
39. Use of a cholera rapid diagnostic test during a mass vaccination campaign in response to an epidemic in Guinea, 2012.
Martinez-Pino I; Luquero FJ; Sakoba K; Sylla S; Haile M; Grais RF; Ciglenecki I; Quilici ML; Page AL
PLoS Negl Trop Dis; 2013; 7(8):e2366. PubMed ID: 23967359
[TBL] [Abstract][Full Text] [Related]
40. Unmasking herd protection by an oral cholera vaccine in a cluster-randomized trial.
Ali M; Qadri F; Kim DR; Islam T; Im J; Ahmmed F; Chon Y; Islam Khan A; Zaman K; Marks F; Clemens JD
Int J Epidemiol; 2019 Aug; 48(4):1252-1261. PubMed ID: 30968110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
